webleads-tracker

Transparence santé, Sunshine Act

New Jersey Finalizes “Gift” Ban of Physicians Working with the Pharmaceutical Industry

In an unusual administrative move – without passing any new laws – on December 22, 2017, the Attorney General of New Jersey finalized new rules governing physician interactions with pharmaceutical companies.
The rule is titled:   LIMITATIONS ON AND OBLIGATIONS ASSOCIATED WITH PRESCRIBER ACCEPTANCE OF COMPENSATION FROM PHARMACEUTICAL MANUFACTURERS.

Pharma Compliance Digital CRM Marketing Transparence DMOS Gift Physicians e1515488830289 New Jersey Finalizes “Gift” Ban of Physicians Working with the Pharmaceutical Industry

Starting January 15, 2018, all contracts and payments entered into by physicians directly with the pharmaceutical industry will be subject to a $10,000 total yearly cap for New Jersey physicians with all pharmaceutical companies. This includes payments from industry for consulting and speaking but exempts research and education related payments. In addition, physicians will be subject to a $15 dollar meal cap, for meals related to all activities.

To read the article by Thomas Sullivan

Check Also

Code of Disclosure, Sunshine Act, Transparency

The biopharmaceutical’s stock took a tumble after the Wall Street Journal asserted that the company has been breaking the Sunshine Act

Shares of MiMedx Group (NASDAQ:MDXG), a biopharmaceutical company focused on regenerative medicine, were down 11% …